Cargando…

Mechanisms of Chemotherapy-Induced Neurotoxicity

Since the first clinical trials conducted after World War II, chemotherapeutic drugs have been extensively used in the clinic as the main cancer treatment either alone or as an adjuvant therapy before and after surgery. Although the use of chemotherapeutic drugs improved the survival of cancer patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Was, Halina, Borkowska, Agata, Bagues, Ana, Tu, Longlong, Liu, Julia Y. H., Lu, Zengbing, Rudd, John A., Nurgali, Kulmira, Abalo, Raquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996259/
https://www.ncbi.nlm.nih.gov/pubmed/35418856
http://dx.doi.org/10.3389/fphar.2022.750507
_version_ 1784684457976922112
author Was, Halina
Borkowska, Agata
Bagues, Ana
Tu, Longlong
Liu, Julia Y. H.
Lu, Zengbing
Rudd, John A.
Nurgali, Kulmira
Abalo, Raquel
author_facet Was, Halina
Borkowska, Agata
Bagues, Ana
Tu, Longlong
Liu, Julia Y. H.
Lu, Zengbing
Rudd, John A.
Nurgali, Kulmira
Abalo, Raquel
author_sort Was, Halina
collection PubMed
description Since the first clinical trials conducted after World War II, chemotherapeutic drugs have been extensively used in the clinic as the main cancer treatment either alone or as an adjuvant therapy before and after surgery. Although the use of chemotherapeutic drugs improved the survival of cancer patients, these drugs are notorious for causing many severe side effects that significantly reduce the efficacy of anti-cancer treatment and patients’ quality of life. Many widely used chemotherapy drugs including platinum-based agents, taxanes, vinca alkaloids, proteasome inhibitors, and thalidomide analogs may cause direct and indirect neurotoxicity. In this review we discuss the main effects of chemotherapy on the peripheral and central nervous systems, including neuropathic pain, chemobrain, enteric neuropathy, as well as nausea and emesis. Understanding mechanisms involved in chemotherapy-induced neurotoxicity is crucial for the development of drugs that can protect the nervous system, reduce symptoms experienced by millions of patients, and improve the outcome of the treatment and patients’ quality of life.
format Online
Article
Text
id pubmed-8996259
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89962592022-04-12 Mechanisms of Chemotherapy-Induced Neurotoxicity Was, Halina Borkowska, Agata Bagues, Ana Tu, Longlong Liu, Julia Y. H. Lu, Zengbing Rudd, John A. Nurgali, Kulmira Abalo, Raquel Front Pharmacol Pharmacology Since the first clinical trials conducted after World War II, chemotherapeutic drugs have been extensively used in the clinic as the main cancer treatment either alone or as an adjuvant therapy before and after surgery. Although the use of chemotherapeutic drugs improved the survival of cancer patients, these drugs are notorious for causing many severe side effects that significantly reduce the efficacy of anti-cancer treatment and patients’ quality of life. Many widely used chemotherapy drugs including platinum-based agents, taxanes, vinca alkaloids, proteasome inhibitors, and thalidomide analogs may cause direct and indirect neurotoxicity. In this review we discuss the main effects of chemotherapy on the peripheral and central nervous systems, including neuropathic pain, chemobrain, enteric neuropathy, as well as nausea and emesis. Understanding mechanisms involved in chemotherapy-induced neurotoxicity is crucial for the development of drugs that can protect the nervous system, reduce symptoms experienced by millions of patients, and improve the outcome of the treatment and patients’ quality of life. Frontiers Media S.A. 2022-03-28 /pmc/articles/PMC8996259/ /pubmed/35418856 http://dx.doi.org/10.3389/fphar.2022.750507 Text en Copyright © 2022 Was, Borkowska, Bagues, Tu, Liu, Lu, Rudd, Nurgali and Abalo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Was, Halina
Borkowska, Agata
Bagues, Ana
Tu, Longlong
Liu, Julia Y. H.
Lu, Zengbing
Rudd, John A.
Nurgali, Kulmira
Abalo, Raquel
Mechanisms of Chemotherapy-Induced Neurotoxicity
title Mechanisms of Chemotherapy-Induced Neurotoxicity
title_full Mechanisms of Chemotherapy-Induced Neurotoxicity
title_fullStr Mechanisms of Chemotherapy-Induced Neurotoxicity
title_full_unstemmed Mechanisms of Chemotherapy-Induced Neurotoxicity
title_short Mechanisms of Chemotherapy-Induced Neurotoxicity
title_sort mechanisms of chemotherapy-induced neurotoxicity
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996259/
https://www.ncbi.nlm.nih.gov/pubmed/35418856
http://dx.doi.org/10.3389/fphar.2022.750507
work_keys_str_mv AT washalina mechanismsofchemotherapyinducedneurotoxicity
AT borkowskaagata mechanismsofchemotherapyinducedneurotoxicity
AT baguesana mechanismsofchemotherapyinducedneurotoxicity
AT tulonglong mechanismsofchemotherapyinducedneurotoxicity
AT liujuliayh mechanismsofchemotherapyinducedneurotoxicity
AT luzengbing mechanismsofchemotherapyinducedneurotoxicity
AT ruddjohna mechanismsofchemotherapyinducedneurotoxicity
AT nurgalikulmira mechanismsofchemotherapyinducedneurotoxicity
AT abaloraquel mechanismsofchemotherapyinducedneurotoxicity